Literature DB >> 7688964

Mutation of the myelin P0 gene in Charcot-Marie-tooth neuropathy type 1.

K Hayasaka1, A Ohnishi, G Takada, Y Fukushima, Y Murai.   

Abstract

We had previously reported that the myelin P0 gene was responsible for Charcot-Marie-Tooth neuropathy type 1B (CMT1B). In this study we found a different mutation of the P0 gene in a family of Charcot-Marie-Tooth neuropathy type 1 without a DNA duplication in chromosome 17p11.2. The mutation, a histidine substitution for arginine at amino acid position 98, is located in the extracellular domain of P0 like as the mutations in the three pedigrees with CMT1B. The extracellular domain forms an immunoglobulin domain responsible for the function of P0 as an adhesion molecule. Alterations in the tertiary structure of the extracellular domain of P0 would modify the function of P0, resulting in an impairment of peripheral myelin compaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688964     DOI: 10.1006/bbrc.1993.1968

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Median nerve motor conduction velocity is concordant with myelin protein zero gene mutation.

Authors:  Yi-Chung Lee; Bing-Wen Soong; Yo-Tsen Liu; Kon-Ping Lin; Ker-Pei Kao; Zin-An Wu
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

Review 2.  Investigation of peripheral neuropathy.

Authors:  J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

3.  Rapid functional analysis in Xenopus oocytes of Po protein adhesive interactions.

Authors:  M Yoshida; D R Colma
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

4.  Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation.

Authors:  M Donaghy; S M Sisodiya; R Kennett; B McDonald; N Haites; C Bell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

5.  High frequency of mutations in codon 98 of the peripheral myelin protein P0 gene in 20 French CMT1 patients.

Authors:  H Rouger; E LeGuern; R Gouider; S Tardieu; N Birouk; M Gugenheim; P Bouche; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

6.  Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q.

Authors:  J M Kwon; J L Elliott; W C Yee; J Ivanovich; N J Scavarda; P J Moolsintong; P J Goodfellow
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

7.  Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP).

Authors:  V Timmerman; A Löfgren; E Le Guern; P Liang; P De Jonghe; J J Martin; D Verhalle; W Robberecht; R Gouider; A Brice; C Van Broeckhoven
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

8.  Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35.

Authors:  Albena Jordanova; Florian P Thomas; Velina Guergueltcheva; Ivailo Tournev; Francisco A A Gondim; Borjana Ishpekova; Els De Vriendt; An Jacobs; Ivan Litvinenko; Neviana Ivanova; Borjan Buzhov; Peter De Jonghe; Ivo Kremensky; Vincent Timmerman
Journal:  Am J Hum Genet       Date:  2003-11-06       Impact factor: 11.025

9.  Rapid screening of myelin genes in CMT1 patients by SSCP analysis: identification of new mutations and polymorphisms in the P0 gene.

Authors:  E Nelis; V Timmerman; P De Jonghe; A Vandenberghe; D Pham-Dinh; A Dautigny; J J Martin; C Van Broeckhoven
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

Review 10.  Ascorbic acid for the treatment of Charcot-Marie-Tooth disease.

Authors:  Burkhard Gess; Jonathan Baets; Peter De Jonghe; Mary M Reilly; Davide Pareyson; Peter Young
Journal:  Cochrane Database Syst Rev       Date:  2015-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.